MS
Therapeutic Areas
Granules India Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Paracetamol (Acetaminophen) | Analgesic & Antipyretic (Pain & Fever) | Approved/Commercial |
| Metformin | Type 2 Diabetes | Approved/Commercial |
| Ibuprofen | Analgesic & Anti-inflammatory | Approved/Commercial |
| Guaifenesin | Expectorant (Cough & Cold) | Approved/Commercial |
| Methocarbamol | Muscle Relaxant | Approved/Commercial |
| Ondansetron | Anti-emetic (Nausea/Vomiting) | Approved/Commercial |
| Losartan | Hypertension | Approved/Commercial |
| Tramadol | Pain Management | Approved/Commercial |
Leadership Team at Granules India
KP
Krishna Prasad Chigurupati
Founder, Chairman & Managing Director
DC
Dr. C. Krishna Prasad
Executive Director
PC
Priyanka Chigurupati
Executive Director
HC
Harsha Chigurupati
Executive Director
MM
M. Madan Mohan Reddy
Chief Financial Officer (CFO)
DR
Dr. Ravi Shankar K.
President - Global HR & Corporate Affairs
DS
Dr. S. P. S. Ranjan
President - Manufacturing
DR
Dr. Rajendra K. Kottapalli
President - Research & Development
DV
Dr. V. S. R. Krishna
President - International Business
DR
Dr. Ramesh Subramanian
President - Quality & Regulatory Affairs